CrossRef McIntyre RS
Although these clinical and animal studies (2125, 4449) indicate that several brain regions are involved in GLP-1RAregulated reward behaviors, the exact mechanisms remain unclear
Retatrutide, a triple-receptor agonist still in Phase 3 clinical trials, has posted some of the most impressive weight loss numbers ever recorded in obesity research, hitting 24.2% body weight reduction in 48 weeks
The scientific leadership of the two largest GLP-1 drugmakers was publicly arguing that the class had crossed from metabolic medicine into the territory of healthspan
Benefit #1: Enhanced Cellular Energy Metabolism (Strongest Evidence) Evidence Quality: Human and animal studies Mechanism: NAD+ restoration and improved mitochondrial function The most robust benefit of 5-amino-1MQ is metabolic enhancement through cellular energy optimization
23 Moreover, CD38 also consumes extracellular NMN, generating NAM, which can be converted to NAD + through NAMPT and NMNAT after crossing the plasma membrane